Han Kang, Chen Xiang, Bian Na, Ma Baoan, Yang Tongtao, Cai Chengkui, Fan QingYu, Zhou Yong, Zhao Ting Bao
Department of Spinal Cord Injury, General Hospital of Jinan Military Area Command of Chinese PLA, Jinan, Shandong, People's Republic of China.
Department of Orthopedic Surgery, Orthopedics Oncology Institute of Chinese PLA, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China.
Oncotarget. 2015 Apr 20;6(11):8875-89. doi: 10.18632/oncotarget.3560.
Metastasis is a leading cause of mortality for osteosarcoma patients. The molecular pathological mechanism remains to be elucidated. In the previously study, we established two osteosarcoma cell lines with different metastatic potentials. Differential expressed genes and proteins regarding metastatic ability have been identified. MicroRNAs are important regulators in tumorigenesis and tumor progression. In this study, microRNA microarray was used to assess the differential expressed miRNAs level between these two cell lines. One of the top ranked miRNAs-miR-195 was identified highly expressing in lowly metastatic cells. It was showed that over-expression of miR-195 substantially inhibits migration and invasion of osteosarcoma cells in vitro and pulmonary metastasis formation in vivo. Meanwhile, CCND1 was identified as the target gene of miR-195 and further studied. More importantly, using real-time PCR, we evaluated the expression of miR-195 and CCND1 in osteosarcoma samples from 107 frozen biopsy tissues and 99 formalin- or paraformalin-fixed, paraffin-embedded (FFPE) tissues. Results indicated lowly expressed miR-195 or highly CCND1 correlated with positive overall survival and their expression inversely related to each other. In summary, our study suggests miR-195 functions as a tumor metastasis suppressor gene by down-regulating CCND1 and can be used as a potential target in the treatment of osteosarcoma.
转移是骨肉瘤患者死亡的主要原因。其分子病理机制仍有待阐明。在先前的研究中,我们建立了两种具有不同转移潜能的骨肉瘤细胞系。已经鉴定出与转移能力相关的差异表达基因和蛋白质。微小RNA是肿瘤发生和肿瘤进展的重要调节因子。在本研究中,使用微小RNA微阵列评估这两种细胞系之间差异表达的微小RNA水平。排名靠前的微小RNA之一——miR-195被鉴定为在低转移细胞中高表达。结果表明,miR-195的过表达在体外显著抑制骨肉瘤细胞的迁移和侵袭以及在体内抑制肺转移的形成。同时,CCND1被鉴定为miR-195的靶基因并进行了进一步研究。更重要的是,我们使用实时PCR评估了107份冷冻活检组织和99份福尔马林或多聚甲醛固定、石蜡包埋(FFPE)组织的骨肉瘤样本中miR-195和CCND1的表达。结果表明,miR-195低表达或CCND1高表达与总体生存率呈正相关,且它们的表达呈负相关。总之,我们的研究表明miR-195通过下调CCND1发挥肿瘤转移抑制基因的作用,可作为骨肉瘤治疗的潜在靶点。